A major move is in the offing as Integra Lifesciences Holdings Corp (IART) market cap hits 3.43 billion

On Monday, Integra Lifesciences Holdings Corp (NASDAQ: IART) was 3.54% up from the session before settling in for the closing price of $42.43. A 52-week range for IART has been $33.44 – $59.33.

#1 Small-Cap Uranium Stock for Ultra-Fast Gains in 2024

We've uncovered THE ONE small-cap uranium stock that has unearthed a near-surface, high-grade uranium discovery in the Saudi Arabia of Uranium — Canada's prolific Athabasca Basin. Best of all, this small-cap uranium stock is currently flying just below Wall Street's radar… giving you the early-entry opportunity around US$0.30 per share. But that won't last long. Drills are turning right now with results set to be released to the market very, very soon.

Learn all about it in this brand new FREE online report.

During the last 5-year period, the sales growth of Healthcare Sector giant was 1.72%. When this article was written, the company’s average yearly earnings per share was at -7.53%. With a float of $66.17 million, this company’s outstanding shares have now reached $83.65 million.

Integra Lifesciences Holdings Corp (IART) Insider Activity

Also, it is sometimes useful to examine the sentiment of large-scale investors toward Integra Lifesciences Holdings Corp stocks. The insider ownership of Integra Lifesciences Holdings Corp is 15.36%, while institutional ownership is 85.61%. The most recent insider transaction that took place on Aug 09, was worth 52,329. In this transaction SVP, Fin & PAO of this company sold 1,177 shares at a rate of $44.46, taking the stock ownership to the 23,458 shares. Before that another transaction happened on Jun 01, when Company’s President & CEO bought 7,792 for $38.50, making the entire transaction worth $299,986. This insider now owns 12,798 shares in total.

Integra Lifesciences Holdings Corp (IART) Earnings and Forecasts

Going through the last 3-months fiscal report unveiled on the 9/29/2023, it has been observed that the corporation posted $0.76 earnings per share (EPS) during the time that was less than consensus figure (set at $0.78) by -$0.02. Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.74 per share during the current fiscal year.

According to the Wall Street analysts, stocks earnings will be around -7.53% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 8.90% during the next five years compared to 21.40% growth over the previous five years of trading.

Integra Lifesciences Holdings Corp (NASDAQ: IART) Trading Performance Indicators

You can see what Integra Lifesciences Holdings Corp (IART) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 1.86. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 2.23. Likewise, its price to free cash flow for the trailing twelve months is 31.29.

For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 1.22, a number that is poised to hit 0.90 in the next quarter and is forecasted to reach 3.44 in one year’s time.

Technical Analysis of Integra Lifesciences Holdings Corp (IART)

Looking closely at Integra Lifesciences Holdings Corp (NASDAQ: IART), its last 5-days average volume was 0.49 million, which is a jump from its year-to-date volume of 0.47 million. As of the previous 9 days, the stock’s Stochastic %D was 97.28%. Additionally, its Average True Range was 1.14.

During the past 100 days, Integra Lifesciences Holdings Corp’s (IART) raw stochastic average was set at 89.89%, which indicates a significant decrease from 99.37% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 30.87% in the past 14 days, which was higher than the 29.91% volatility it showed in the past 100 days.

At the time of writing, stock’s 50-day Moving Average is $42.16, while its 200-day Moving Average is $41.74. However, in the short run, Integra Lifesciences Holdings Corp’s stock first resistance to watch stands at $44.42. Second resistance stands at $44.90. The third major resistance level sits at $45.85. If the price goes on to break the first support level at $42.99, it is likely to go to the next support level at $42.04. Should the price break the second support level, the third support level stands at $41.56.

Integra Lifesciences Holdings Corp (NASDAQ: IART) Key Stats

There are 78,176K outstanding shares of the company, which has a market capitalization of 3.43 billion. As of now, sales total 1,558 M while income totals 180,550 K. Its latest quarter income was 382,420 K while its last quarter net income were 19,500 K.